CRADD and neoplasm: Overall, these data demonstrate that the adaptor protein Raidd is not limiting Myc-driven tumorigenesis thereby uncoupling the tumor-suppressor function of Caspase-2 from Raidd-dependent autoactivation and the oncogenic potential of Pidd1 from Raidd-modulated NF-κB signaling.